Evidence map›Paper›PMID 31866068›Full record

ArticleCell2020

Restricted Clonality and Limited Germinal Center Reentry Characterize Memory B Cell Reactivation by Boosting.

Luka Mesin, Ariën Schiepers, Jonatan Ersching, Alexandru Barbulescu, Cecília B Cavazzoni, Alessandro Angelini, Takaharu Okada, Tomohiro Kurosaki, Gabriel D Victora

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in Cell, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05272735 (HBV Vaccination of Healthy Volunteers to Evaluate the Composition of Germinal Centers), which is not on this map. Cited by 214 papers.

0numbers the graph read from it
0cells of the map it votes in
214citing papers in PubMed
15.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05272735 phase4terminatednot on this mapstarted 2022, after this paper: background citation

HBV Vaccination of Healthy Volunteers to Evaluate the Composition of Germinal Centers

TypeinterventionalSponsorRockefeller UniversityRan2022 to 2025Enrolled9ConditionsHepatitis BArmsHepatitis B Vaccine (Recombinant)
3 · Its place in the literature

Who cites it

214 citing papers in PubMed, 344 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Review
  5. Humoral immunity in cancer.Signal transduction and targeted therapy · 2026
    Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Observational
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Clonal dynamics of germinal center refueling by secondary immunization.bioRxiv : the preprint server for biology · 2026
    Article
  19. Article
  20. Article

154 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 4 countries.

Luka MesinLaboratory of Lymphocyte Dynamics, The Rockefeller University, New York, NY, USA.
Ariën SchiepersLaboratory of Lymphocyte Dynamics, The Rockefeller University, New York, NY, USA.
Jonatan ErschingLaboratory of Lymphocyte Dynamics, The Rockefeller University, New York, NY, USA.
Alexandru BarbulescuLaboratory of Lymphocyte Dynamics, The Rockefeller University, New York, NY, USA; Weill Cornell/Rockefeller/Sloan Kettering Tri-Institutional MD-PhD Program, New York, NY, USA.
Cecília B CavazzoniLaboratory of Lymphocyte Dynamics, The Rockefeller University, New York, NY, USA; Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
Alessandro AngeliniDepartment of Molecular Sciences and Nanosystems, Ca' Foscari University of Venice, Venice, Italy; European Centre for Living Technology (ECLT), Venice, Italy.
Takaharu OkadaLaboratory for Tissue Dynamics, RIKEN Center for Integrative Medical Sciences, Yokohama, Kanagawa, Japan; Graduate School of Medical Life Science, Yokohama City University, Yokohama, Kanagawa, Japan.
Tomohiro KurosakiLaboratory of Lymphocyte Differentiation, WPI Immunology Frontier Research Center, Osaka University, Suita, Osaka, Japan; Laboratory for Lymphocyte Differentiation, RIKEN Center for Integrative Medical Sciences, Yokohama, Kanagawa, Japan.
Gabriel D VictoraLaboratory of Lymphocyte Dynamics, The Rockefeller University, New York, NY, USA. Electronic address: victora@rockefeller.edu.
Rockefeller University · USRIKEN Center for Integrative Medical Sciences · JPEuropean Centre for Living Technology · ITTri-Institutional PhD Program in Chemical Biology · US

Funding

Weill Cornell/Rockefeller/Sloan-Kettering MST ProgramT32GM007739 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI HSU, KATHARINE C · 1985 to 2023
$51.1M
Quantifying Cell-Cell Interactions in the Immune System by Trans-Synaptic LabelingDP1AI144248 · NIAID · ROCKEFELLER UNIVERSITY · PI VICTORA, GABRIEL D · 2018 to 2022
$5.9M
Dynamics of Antigen-Driven Selection in Germinal CentersR01AI119006 · NIAID · ROCKEFELLER UNIVERSITY · PI Gabriel D Victora · 2017 to 2026
$5.7M
Molecular control of germinal center selection and affinity maturationR01AI139117 · NIAID · ROCKEFELLER UNIVERSITY · PI Gabriel D Victora · 2018 to 2026
$3.9M
IN VIVO APPROACHES TO DISSECTING B CELL-T CELL COOPERATION IN GERMINAL CENTERSDP5OD012146 · OD · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI VICTORA, GABRIEL D · 2012 to 2016
$2.4M
NIAID NIH HHS DP1 AI144248NIAID NIH HHS R01 AI119006NIAID NIH HHS R01 AI139117NIGMS NIH HHS T32 GM007739NIH HHS DP5 OD012146
6 · The paper itself

Abstract

Repeated exposure to pathogens or their antigens triggers anamnestic antibody responses that are higher in magnitude and affinity than the primary response. These involve reengagement of memory B cell (MBC) clones, the diversity and specificity of which determine the breadth and effectiveness of the ensuing antibody response. Using prime-boost models in mice, we find that secondary responses are characterized by a clonality bottleneck that restricts the engagement of the large diversity of MBC clones generated by priming. Rediversification of mutated MBCs is infrequent within secondary germinal centers (GCs), which instead consist predominantly of B cells without prior GC experience or detectable clonal expansion. Few MBC clones, generally derived from higher-affinity germline precursors, account for the majority of secondary antibody responses, while most primary-derived clonal diversity is not reengaged detectably by boosting. Understanding how to counter this bottleneck may improve our ability to elicit antibodies to non-immunodominant epitopes by vaccination.

Indexed as

Adaptive ImmunityAnimalsAntibody FormationAntigensB-LymphocytesCell LineCHO CellsCricetulusFemaleGerminal CenterHumansImmunologic MemoryMaleMiceMice, Inbred C57BLMice, TransgenicAntigensaffinity maturationantibody responseclonal dynamicsgerminal center memory B cellimmunological memoryinfluenza A virusmemory reactivation

Identifiers

PMID31866068
PMCPMC6958527
OpenAlexW2995806710

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.